Table 2.
Drug Combinations | FICI |
---|---|
GA + AMP | 0.504 (A) |
GA + Amoxicillin | 1.008 (I) |
GA + Ceftiofur | 1.001 (I) |
GA + Penicillin G | 1.004 (I) |
GA + Cefotaxime | 0.563 (A) |
GA + ERY | 1.002 (I) |
GA + Thiamphenicol | 0.281 (S) |
GA + Marbofloxacin | 0.625 (A) |
HAMA + AMP | 1.001 (I) |
HAMA + Amoxicillin | 0.625 (A) |
HAMA + Ceftiofur | 1.002 (I) |
HAMA + Penicillin G | 1.002 (I) |
HAMA + Cefotaxime | 1.001 (I) |
HAMA + ERY | 0.375 (S) |
HAMA + Thiamphenicol | 0.500 (S) |
HAMA + Marbofloxacin | 0.625 (A) |
Epicatechin + AMP | 1.004 (I) |
Epicatechin + Amoxicillin | 1.001 (I) |
Epicatechin + Ceftiofur | 0.625 (A) |
Epicatechin + Penicillin G | 1.002 (I) |
Epicatechin + Cefotaxime | 0.563 (A) |
Epicatechin + ERY | 0.504 (A) |
Epicatechin + Thiamphenicol | 1.008 (I) |
Epicatechin + Marbofloxacin | 0.504 (A) |
AMP + Epicatechin gallate | 1.004 (I) |
Amoxicillin + Epicatechin gallate | 1.001 (I) |
Ceftiofur + Epicatechin gallate | 0.625 (A) |
Penicillin-G + Epicatechin gallate | 1.002 (I) |
Cefotaxime + Epicatechin gallate | 1.002 (I) |
ERY + Epicatechin gallate | 1.001 (I) |
Thiamphenicol + Epicatechin gallate | 0.625 (A) |
Marbofloxacin + Epicatechin gallate | 0.516 (A) |
Epigallocatechin + AMP | 0.504 (A) |
Epigallocatechin + Amoxicillin | 1.008 (I) |
Epigallocatechin + Ceftiofur | 0.625 (A) |
Epigallocatechin + Penicillin G | 1.008 (I) |
Epigallocatechin + Cefotaxime | 0.502 (A) |
Epigallocatechin + ERY | 0.516 (A) |
Epigallocatechin + Thiamphenicol | 1.008 (I) |
Epigallocatechin + Marbofloxacin | 0.504 (A) |
Five independent experiments (n = 5) were performed. A, additive; AMP, ampicillin; ERY, erythromycin; FICI, fractional inhibitory concentration index; GA, gallic acid; HAMA, hamamelitannin; I, indifferent; S, synergy; Synergy, FICI ≤ 0.5; Additive, 0.5 < FICI ≤ 1; Indifferent, 1 < FICI ≤ 4; Antagonist, FICI > 4.